G01N 2333/70596
Molecules with a "cd"-designation not provided for elsewhere in g01n2333/705
Official title: Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
G01N2333/70596 (Molecules with a "cd"-designation not provided for elsewhere in g01n2333/705) appears on 828 US grants and 1,799 published applications in this corpus.
Search patents in G01N- Granted patents
- 828
- Published applications
- 1,799
- Assignees
- 917
- Inventors
- 3,800
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 2 |
| 2003 | 2 | 16 |
| 2004 | 3 | 24 |
| 2005 | 2 | 24 |
| 2006 | 5 | 22 |
| 2007 | 7 | 24 |
| 2008 | 15 | 27 |
| 2009 | 7 | 39 |
| 2010 | 17 | 37 |
| 2011 | 18 | 50 |
| 2012 | 23 | 43 |
| 2013 | 22 | 49 |
| 2014 | 21 | 67 |
| 2015 | 41 | 120 |
| 2016 | 55 | 130 |
| 2017 | 61 | 122 |
| 2018 | 76 | 118 |
| 2019 | 77 | 110 |
| 2020 | 67 | 122 |
| 2021 | 53 | 104 |
| 2022 | 59 | 116 |
| 2023 | 43 | 104 |
| 2024 | 47 | 125 |
| 2025 | 60 | 124 |
| 2026 | 40 | 79 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-ABCG2 antibodies and uses thereof6 Oct 2026US 12,753,241 B2William Robert Arathoon Living Trust Dated August 29, 2016
- Monoclonal antibody used for diagnosis and early onset of prostate cancer6 Oct 2026US 12,753,244 B2Taipei Medical University
- Monoclonal antibody drug sensitivity in multiple myeloma patients6 Oct 2026US 12,754,180 B2The Regents of the University of Colorado, a body corporate
- Multi-domain CD1a antagonist/PD-1 agonist antibody molecules15 Sep 2026US 12,735,491 B2Immunocore Limited
- Artificial intelligence for early cancer detection8 Sep 2026US 12,730,108 B2Regents of the University of Minnesota
- Multi-domain molecules8 Oct 2026US 2026/0308260 A1Immunocore Limited
- Combination therapy of polio virus receptor inhibitors and fucose8 Oct 2026US 2026/0309713 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Use of kit for diagnosing or assisting in diagnosis of spn1 Oct 2026US 2026/0298937 A1Junmo (Beijing) Biotherapeutics Co., Ltd.
- Human cd6 binding molecules24 Sep 2026US 2026/0284212 A1The Cleveland Clinic Foundation
- Assays for characterization of extracellular vesicles and methods of using the same17 Sep 2026US 2026/0276637 A1City of Hope
Most cited
By later US patents
- Microfluidic device for cell separation and uses thereof147US 8,304,230 B2The General Hospital Corporation · 2012
- Microfluidic device for cell separation and uses thereof111US 8,372,579 B2The General Hospital Corporation · 2013
- Antibodies that bind PD-L1 and uses thereof99US 9,212,224 B2Bristol-Myers Squibb Company · 2015
- Remotely or locally actuated refrigerator lock with temperature and humidity detection97US 7,728,711 B2S&S X-Ray Products, Inc. · 2010
- Antibodies against CD38 for treatment of multiple myeloma94US 7,829,673 B2Genmab A/S · 2010